RNH1 Antikörper (AA 101-200)
-
- Target Alle RNH1 Antikörper anzeigen
- RNH1 (Ribonuclease/angiogenin Inhibitor 1 (RNH1))
-
Bindungsspezifität
- AA 101-200
-
Reaktivität
- Human, Ratte, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser RNH1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Human, Maus, Ratte
- Homologie
- Cow,Pig
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human Ribonuclease Inhibitor
- Isotyp
- IgG
- Top Product
- Discover our top product RNH1 Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
-
Overexpression of ribonuclease inhibitor defines good prognosis and suppresses proliferation and metastasis in human colorectal cancer cells via PI3K/AKT pathway." in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, (2014) (PubMed).
: "
-
Overexpression of ribonuclease inhibitor defines good prognosis and suppresses proliferation and metastasis in human colorectal cancer cells via PI3K/AKT pathway." in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, (2014) (PubMed).
-
- Target
- RNH1 (Ribonuclease/angiogenin Inhibitor 1 (RNH1))
- Andere Bezeichnung
- Ribonuclease Inhibitor (RNH1 Produkte)
- Synonyme
- RAI antikoerper, RNH antikoerper, AW546468 antikoerper, C80305 antikoerper, RNH1 antikoerper, Rnh antikoerper, Rnh1 antikoerper, im:7039360 antikoerper, si:ch211-213a13.3 antikoerper, wu:fd55g05 antikoerper, ribonuclease/angiogenin inhibitor 1 antikoerper, ribonuclease inhibitor antikoerper, RNH1 antikoerper, Rnh1 antikoerper, Tc00.1047053511893.10 antikoerper, Tc00.1047053507583.70 antikoerper, rnh1 antikoerper
- Hintergrund
-
Synonyms: RAI, RNH, Ribonuclease inhibitor, Placental ribonuclease inhibitor, Placental RNase inhibitor, Ribonuclease/angiogenin inhibitor 1, RNH1, PRI
Background: Ribonuclease inhibitor which inhibits RNASE1, RNASE2 and ANG. May play role in redox homeostasis.
- Gen-ID
- 6050
- UniProt
- P13489
-